These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 1853948

  • 1. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function.
    O'Keane V, Dinan TG.
    Am J Psychiatry; 1991 Aug; 148(8):1009-15. PubMed ID: 1853948
    [Abstract] [Full Text] [Related]

  • 2. d-fenfluramine-induced prolactin responses in mania: evidence for serotonergic subsensitivity.
    Thakore JH, O'Keane V, Dinan TG.
    Am J Psychiatry; 1996 Nov; 153(11):1460-3. PubMed ID: 8890681
    [Abstract] [Full Text] [Related]

  • 3. Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects.
    Cleare AJ, Murray RM, O'Keane V.
    Neuropsychopharmacology; 1996 May; 14(5):349-54. PubMed ID: 8703303
    [Abstract] [Full Text] [Related]

  • 4. Cortisol, ACTH, prolactin and beta-endorphin responses to fenfluramine administration in major-depressed patients.
    Maes M, Jacobs MP, Suy E, Minner B, Raus J.
    Neuropsychobiology; 1989 May; 21(4):192-6. PubMed ID: 2561010
    [Abstract] [Full Text] [Related]

  • 5. Depression in premenopausal women: gonadal hormones and serotonergic system assessed by D-fenfluramine challenge test.
    Rajewska J, Rybakowski JK.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):705-9. PubMed ID: 12787860
    [Abstract] [Full Text] [Related]

  • 6. Hormonal responses to fenfluramine in depressed and control subjects.
    Mitchell P, Smythe G.
    J Affect Disord; 1990 May; 19(1):43-51. PubMed ID: 2140846
    [Abstract] [Full Text] [Related]

  • 7. Assessment of serotonergic function in major depression using d-fenfluramine: relation to clinical variables and antidepressant response.
    Cleare AJ, Murray RM, O'Keane V.
    Biol Psychiatry; 1998 Oct 01; 44(7):555-61. PubMed ID: 9787879
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of the prolactin response to d-fenfluramine in drug-naive schizophrenic patients.
    Abel KM, O'Keane V, Murray RM.
    Br J Psychiatry; 1996 Jan 01; 168(1):57-60. PubMed ID: 8770429
    [Abstract] [Full Text] [Related]

  • 9. Interrelationship of age, depression, and central serotonergic function: evidence from fenfluramine challenge studies.
    Lerer B, Gillon D, Lichtenberg P, Gorfine M, Gelfin Y, Shapira B.
    Int Psychogeriatr; 1996 Jan 01; 8(1):83-102. PubMed ID: 8805090
    [Abstract] [Full Text] [Related]

  • 10. Prolactin and cortisol responses to fenfluramine in Parkinson's disease.
    Kostić VS, Lecić D, Doder M, Marinković J, Filipović S.
    Biol Psychiatry; 1996 Oct 15; 40(8):769-75. PubMed ID: 8894070
    [Abstract] [Full Text] [Related]

  • 11. Hormonal responses to fenfluramine in depressive subtypes.
    Mitchell P, Smythe G, Parker G, Wilhelm K, Hickie I, Brodaty H, Boyce P.
    Br J Psychiatry; 1990 Oct 15; 157():551-7. PubMed ID: 2131137
    [Abstract] [Full Text] [Related]

  • 12. Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression.
    Siever LJ, Murphy DL, Slater S, de la Vega E, Lipper S.
    Life Sci; 1984 Mar 12; 34(11):1029-39. PubMed ID: 6700367
    [Abstract] [Full Text] [Related]

  • 13. Hormone responses to fenfluramine and placebo challenge in endogenous depression.
    Lichtenberg P, Shapira B, Gillon D, Kindler S, Cooper TB, Newman ME, Lerer B.
    Psychiatry Res; 1992 Aug 12; 43(2):137-46. PubMed ID: 1410069
    [Abstract] [Full Text] [Related]

  • 14. D-fenfluramine-induced prolactin and cortisol release in major depression: response to treatment.
    O'Keane V, McLoughlin D, Dinan TG.
    J Affect Disord; 1992 Nov 12; 26(3):143-50. PubMed ID: 1460163
    [Abstract] [Full Text] [Related]

  • 15. 5-HT neuroendocrine function in major depression: prolactin and cortisol responses to D-fenfluramine.
    Park SB, Williamson DJ, Cowen PJ.
    Psychol Med; 1996 Nov 12; 26(6):1191-6. PubMed ID: 8931165
    [Abstract] [Full Text] [Related]

  • 16. Enhanced serotonergic responsivity following electroconvulsive therapy in patients with major depression.
    Shapira B, Lerer B, Kindler S, Lichtenberg P, Gropp C, Cooper T, Calev A.
    Br J Psychiatry; 1992 Feb 12; 160():223-9. PubMed ID: 1540763
    [Abstract] [Full Text] [Related]

  • 17. No effect of depression on [(15)O]H2O PET response to intravenous d-fenfluramine.
    Meyer JH, Kennedy S, Brown GM.
    Am J Psychiatry; 1998 Sep 12; 155(9):1241-6. PubMed ID: 9734549
    [Abstract] [Full Text] [Related]

  • 18. The prolactin response to fenfluramine in depression: effects of melancholia and baseline cortisol.
    Mulder RT, Porter RJ, Joyce PR.
    J Psychopharmacol; 2003 Mar 12; 17(1):97-102. PubMed ID: 12680745
    [Abstract] [Full Text] [Related]

  • 19. HPA-axis hormones and prolactin responses to dextro-fenfluramine in depressed patients and healthy controls.
    Maes M, D'Hondt P, Suy E, Minner B, Vandervorst C, Raus J.
    Prog Neuropsychopharmacol Biol Psychiatry; 1991 Mar 12; 15(6):781-90. PubMed ID: 1662403
    [Abstract] [Full Text] [Related]

  • 20. Prolactin response to D-fenfluramine in outpatients with major depression.
    Kavoussi RJ, Kramer J, Hauger RL, Coccaro EF.
    Psychiatry Res; 1998 Jul 13; 79(3):199-205. PubMed ID: 9704866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.